Chemical giant Bayer challenging Europe’s neonicotinoids ban

| | July 30, 2018
neonic
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Bayer will appeal…the recent ruling of the General Court of the European Union (EU) to ban neonicotinoids.

[T]he German multinational pharmaceutical company stated that it is concerned that the verdict, announced in April, could have far-reaching consequences for the certainty and predictability of active substance approvals in the EU.

Bayer also outlined that it stands by the safety of its products – which have been approved by regulatory bodies around the globe – and reiterates the value that neonicotinoids have for farmers in managing pests effectively.

By appealing against the verdict, Bayer aims to ensure that some general interpretations of the crop protection law established by the court are re-considered.

Related article:  Viewpoint: Organic industry anti-pesticide 'propaganda' threatens to cripple American agriculture

Read full, original article: Bayer to appeal court verdict on neonicotinoids

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend